EUVIMEDEUVIMED entdecken
Crossref

The Factors Reducing Relative Dose Intensity of Cisplatin and Vinorelbine as Adjuvant Chemotherapy in Patients with Non-Small Cell Lung Cancer

Ryo Inose, Katsuyuki Takahashi, Naruo Yoshimura, Tomoya Kawaguchi, Mitsutaka Takada, Katsuya Nagayama

Oncomedicine · 2018

DOI: 10.7150/oncm.21294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncomedicine, 2018. Verfasst von Ryo Inose und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Inose, R., Takahashi, K., Yoshimura, N., Kawaguchi, T., Takada, M., & Nagayama, K. (2018). The Factors Reducing Relative Dose Intensity of Cisplatin and Vinorelbine as Adjuvant Chemotherapy in Patients with Non-Small Cell Lung Cancer. Oncomedicine. https://doi.org/10.7150/oncm.21294

Vancouver

Inose R, Takahashi K, Yoshimura N, Kawaguchi T, Takada M, Nagayama K. The Factors Reducing Relative Dose Intensity of Cisplatin and Vinorelbine as Adjuvant Chemotherapy in Patients with Non-Small Cell Lung Cancer. Oncomedicine. 2018. doi:10.7150/oncm.21294

BibTeX
@article{Inose2018,
  author = {Inose, Ryo and Takahashi, Katsuyuki and Yoshimura, Naruo and Kawaguchi, Tomoya and Takada, Mitsutaka and Nagayama, Katsuya},
  title = {The Factors Reducing Relative Dose Intensity of Cisplatin and Vinorelbine as Adjuvant Chemotherapy in Patients with Non-Small Cell Lung Cancer},
  journal = {Oncomedicine},
  year = {2018},
  doi = {10.7150/oncm.21294}
}
Kostenlos starten →